The Centers for Disease Control and Prevention yesterday awarded more than $14 million to 34 groups to develop new approaches to combatting antibiotic resistance. Some of the grants, part of CDC’s Antibiotic Resistance Solutions Initiative, will be directed at research on how microorganisms already present in the human body may be used to predict and prevent new infections.“Understanding the role the microbiome plays in antibiotic-resistant infections is necessary to protect the public’s health,” said CDC Director Tom Frieden, M.D. “We think it is key to innovative approaches to combat antibiotic resistance, protect patients, and improve antibiotic use.” For a list of the awardees, see the CDC news release.

Related News Articles

Headline
Randy Fagin, M.D., chief quality officer at HCA Healthcare, shares how one of the nation’s largest health systems is putting artificial intelligence into…
Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…
Headline
The Federal Trade Commission Sept. 5 voted 3-1 to vacate the noncompete final rule issued last year by the previous administration. The rule banned, as an…
Headline
The White House Sept. 5 issued an executive order modifying the scope of reciprocal tariffs announced in April to establish a framework of trade deals with…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The Federal Trade Commission Sept. 4 released a request for information on noncompete agreements. The agency said it seeks to “better understand the scope,…